Literature DB >> 8546169

Correction of glucose concentration interference on Jaffé kinetic creatinine assay in peritoneal dialysis.

G Da Rin1, G Amici, G Virga, C Bardin, P Calzavara, C Bocci.   

Abstract

Overestimation of creatinine measurement using the Jaffé kinetic method in peritoneal dialysis solutions, due to glucose interference, has been quantified and corrected through the elaboration of linear formulas obtained from 110 recovery and 301 biological tests. The added pure powdered creatinine and enzymatic method were considered as references after proven accuracy. Considering creatinine as well as glucose concentration interference, we obtained correction formulas from multiple regression application. All the computed formulas gave satisfactory corrections but different accuracy levels. The best model in biological samples was: Corrected CR = K1JafféCr + K2Glucose (all values in mg/dl) where K1 = 0.973 and K2 = -0.00035 (Rsq = 0.987, F ratio = 10,945, p = 0.00001). Applying formulas to biological samples there was a drop in accuracy, possibly explained by the presence of numerous unidentified substances in peritoneal dialysis biological samples that can amplify scatter. Every laboratory can reduce the error of the Jaffé kinetic assay by calculating their own correction formula in relation to the method and instrument used, because Jaffé kinetic assay gives different results with different kinetic windows. So, especially when applied to peritoneal dialysis fluid measurements, if a creatinine assay reference method is not available, the correction formula can be applied directly as given. Otherwise the method we have described can be followed with a well-structured creatinine recovery fest to identify and quantify assay interferences.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8546169     DOI: 10.1159/000168890

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  1 in total

1.  Interference with the Jaffé method for creatinine following 5-aminolevulinic acid administration.

Authors:  Harry Quon; Craig E Grossman; Rebecca L King; Mary Putt; Keri Donaldson; Larry Kricka; Jarod Finlay; Timothy Zhu; Andrea Dimofte; Kelly Malloy; Keith A Cengel; Theresa M Busch
Journal:  Photodiagnosis Photodyn Ther       Date:  2010-08-30       Impact factor: 3.631

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.